A share price of Alaunos Therapeutics Inc [TCRT] is currently trading at $2.95, down -30.09%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TCRT shares have gain 102.05% over the last week, with a monthly amount glided 96.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alaunos Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $1.31 and $18.20. Alaunos Therapeutics Inc [NASDAQ: TCRT] shares were valued at $2.95 at the most recent close of the market.
Analyzing the TCRT fundamentals
Trailing Twelve Months sales for Alaunos Therapeutics Inc [NASDAQ:TCRT] were 0.01M which represents 300.00% growth. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -534.78%, Pretax Profit Margin comes in at -520.0%, and Net Profit Margin reading is -520.0%. To continue investigating profitability, this company’s Return on Assets is posted at -1.7, Equity is -1.4 and Total Capital is -2.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.12 points at the first support level, and at 1.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.57, and for the 2nd resistance point, it is at 6.18.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Alaunos Therapeutics Inc [NASDAQ:TCRT] is 3.98. As well, the Quick Ratio is 3.98, while the Cash Ratio is 1.58. Considering the valuation of this stock, the price to sales ratio is 472.00, the price to book ratio is 2.29.
Transactions by insiders
Recent insider trading involved Vieser Jaime, Director, that happened on Dec 31 ’24 when 3000.0 shares were sold. Director, Vieser Jaime completed a deal on Dec 31 ’24 to buy 3000.0 shares.
